Using “Nature’s Mistakes” as a Window into Lafora Disease
ASBMB Today explores the biology of Lafora disease, emerging therapeutic strategies, and the essential role of collaboration among researchers, patients, families, and Chelsea’s Hope.
This author has not written his bio yet.
But we are proud to say that Kun Yan contributed 3 entries already.
ASBMB Today explores the biology of Lafora disease, emerging therapeutic strategies, and the essential role of collaboration among researchers, patients, families, and Chelsea’s Hope.
Patient Worthy profiles Chelsea’s Hope, the families affected by Lafora disease, and the community-led effort to support the ION283 safety study and advance urgently needed research.
The Good News Movement highlights the ION283 human safety study and the international community effort supporting research toward a potential Lafora disease therapy.
The mission of Chelsea’s Hope is to improve the lives of those affected by Lafora disease and help accelerate the development of treatments.
Chelsea’s Hope Lafora Children Research Fund is an IRS 501(c)3 nonprofit organization. EIN: 27-1008382
Chelsea’s Hope c/o Dr. Donohue
976 Maywick Dr.
Lexington, KY 40504
Use ICD-10 code G40.C for Lafora.
